On occasion of autumn harvest season, ConFlow MedTech is proud to announce the successful completion of an external audit for the certification of its Intellectual Property Management System. Thanks to the efficient collaboration of our colleagues, ConFlow MedTech established a standardized intellectual property management system in 2021, tailored to its unique strengths and industry-specific characteristics. This system is set to operate seamlessly throughout 2022. The audit team commended ConFlow MedTech for its outstanding intellectual property management efforts, leading to the successful certification audit. On October 28, 2022, we received the "Intellectual Property Management System Certification Certificate.
ConFlow MedTech has now formally integrated the research and development, manufacturing, and sales of all structural heart disease and peripheral intervention devices into compliance with GB/T 29490-2013, the "Enterprise Intellectual Property Management Standards" system.
Since its inception, ConFlow MedTech has consistently upheld its corporate ethos of diligence, practicality, and efficient collaboration, while also consistently enhancing and formalizing its intellectual property management efforts. As of the date of this release, ConFlow MedTech has advanced the utilization of over 50 patents across diverse categories, including inventions, utility models, design aesthetics, PCT, and international patents. Furthermore, ConFlow MedTech is actively establishing a systematic framework for future innovative technology reserves. In the foreseeable future, ConFlow MedTech is poised to emerge as a leading independent research and development technology company, driven by innovation.
Ms. Chen Xiumin, Founder and CEO of ConFlow MedTech, emphasized the company's commitment to advancing the field of structural heart disease through the pursuit of the development of original innovative technologies and products. All of our research initiatives have applied for core patents and are actively establishing international intellectual property rights, thus providing a strong foundation for ConFlow MedTech's expansion into global markets.
The certification of our Intellectual Property Management System represents a significant acknowledgment of ConFlow MedTech's meticulous approach to intellectual property management within the cardiovascular field. We are confident that the company's intellectual property management work will live up to expectations and provide strong support for ConFlow MedTech to become a leading, globally influential innovator in the cardiovascular domain.
-
September 17,2021Celebrating its one-year milestone, ConFlow MedTech successfully concluded its first-anniversary event, joined by supporters and partners.
-
July 24,2023Good News | ConFlow MedTech was awarded as "Specialized and Sophisticated SME" in Shanghai City
-
September 18,2023Thank you for being with us as we celebrate the third anniversary of ConFlow MedTech's establishment!
Pursue further excellence!
